Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review

IntroductionChronic kidney disease (CKD) is a major public-health problem that increases the risk of end-stage kidney disease (ESKD), cardiovascular diseases, and other complications. Kidney transplantation is a renal-replacement therapy that offers better survival compared to dialysis. Antibody-med...

Full description

Bibliographic Details
Main Authors: Lara Cabezas, Thomas Jouve, Paolo Malvezzi, Benedicte Janbon, Diane Giovannini, Lionel Rostaing, Johan Noble
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
kidney transplantation
tocilizumab
antibody-mediated rejection
chronic active antibody-mediated rejection
estimated glomerular filtration rate
donor-specific alloantibody
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.839380/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.839380/full

Similar Items